<--- Back to Details
First PageDocument Content
Clinical research / Food and Drug Administration / Pharmaceutical industry / Drug safety / Savient pharmaceuticals / Pharmaceuticals policy / Pegloticase / Biologic license application / PEGylation / Validation / Pharmacovigilance / Clinical trial
Date: 2016-07-11 17:00:04
Clinical research
Food and Drug Administration
Pharmaceutical industry
Drug safety
Savient pharmaceuticals
Pharmaceuticals policy
Pegloticase
Biologic license application
PEGylation
Validation
Pharmacovigilance
Clinical trial

Microsoft Word - Savient Update on KRYSTEXXA BLA Filingdoc

Add to Reading List

Source URL: www.mvpharm.com

Download Document from Source Website

File Size: 40,14 KB

Share Document on Facebook

Similar Documents

House of Commons Health Committee The Influence of the Pharmaceutical Industry

DocID: 1v3YA - View Document

Speakers Confirmed BD Biosciences Industry Days A roadshow of talks specifically tailored to those working in the biotechnology, clinical research and pharmaceutical industry. Join leaders in the field and BD experts for

DocID: 1uWLK - View Document

NEWS RELEASE Copley Scientific celebrates seven decades of responsive service to the pharmaceutical industry 17th May 2016: Nottingham, UK: Copley Scientific, a family-owned company that began supplying glassware to the

DocID: 1utWK - View Document

2nd APV Conference on “Highly Potent Drug Products in the Pharmaceutical Industry” 26 to 27 September 2018 Mannheim, Germany

DocID: 1utU5 - View Document

Index of abbreviations AAMC – Australian Army Medical Corps AB – Artium Baccalaureus, Bachelor of Arts Aberd – Aberdeen ABPI – Association of the British Pharmaceutical Industry AC – Companion, Order of Austral

DocID: 1ushC - View Document